Whalestream has ceased operations permanently

Healthcare Sector

PFE

Market Tracker

$24.23
-0.02
(-0.09%)
7:00 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/17/2026 CALL $25.00 56,001 +31,000 +124.00%
07/17/2026 PUT $25.00 56,001 +31,000 +124.00%
07/09/2026 CALL $26.00 20,000 +20,000
07/09/2026 PUT $26.00 20,000 +20,000
08/21/2026 CALL $26.00 40,615 +5,762 +16.53%
07/17/2026 CALL $25.00 20,516 +5,494 +36.57%
07/10/2026 PUT $26.00 157 -138 -46.78%
01/15/2027 CALL $30.00 55,819 -151 -0.27%
07/17/2026 CALL $27.00 17,159 -161 -0.93%
07/02/2026 PUT $25.50 36 -177 -83.10%
01/15/2027 CALL $27.00 53,551 -253 -0.47%
07/02/2026 PUT $25.00 3,192 -302 -8.64%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • 3 High-Yield Dividend Stocks Paying 5% or More That Are Worth Buying Now

    07/12 03:25 am

    The Motley Fool

    Read more
  • NCLA to Fifth Circuit: Revive Suit Against Gov’t-Led Censorship of Covid Vaccine-Injured Americans

    07/08 06:38 pm

    GlobeNewswire Inc.

    Read more
  • BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

    07/08 07:28 am

    The Motley Fool

    Read more
  • 2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now

    07/07 06:30 pm

    The Motley Fool

    Read more
  • Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider

    07/07 06:42 am

    GlobeNewswire Inc.

    Read more
  • Meet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July.

    07/06 08:37 am

    The Motley Fool

    Read more
  • Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

    07/03 11:14 am

    The Motley Fool

    Read more
  • Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

    07/02 06:33 am

    The Motley Fool

    Read more
  • Big Pharma Has a Case of Merger Mania

    06/30 12:26 am

    The Motley Fool

    Read more
  • AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

    06/29 11:21 am

    The Motley Fool

    Read more
  • A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?

    06/28 04:30 am

    The Motley Fool

    Read more
  • Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

    06/27 03:15 pm

    The Motley Fool

    Read more
  • An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?

    06/25 11:18 am

    The Motley Fool

    Read more
  • Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

    06/25 06:00 am

    GlobeNewswire Inc.

    Read more
  • 2 High-Yield Dividend Stocks to Buy and Hold for a Decade

    06/23 04:30 pm

    The Motley Fool

    Read more
  • Could Pfizer Stock Be Your Ticket to Generational Wealth?

    06/21 09:15 pm

    The Motley Fool

    Read more
  • Want to Retire on $500,000? 3 Stocks to Buy and Never Sell

    06/21 04:24 am

    The Motley Fool

    Read more
  • Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?

    06/20 05:15 pm

    The Motley Fool

    Read more
  • Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

    06/18 07:09 pm

    The Motley Fool

    Read more
  • FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

    06/18 11:29 am

    Benzinga

    Read more
  • Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors

    06/15 04:00 am

    GlobeNewswire Inc.

    Read more
  • How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

    06/13 06:15 pm

    The Motley Fool

    Read more
  • Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

    06/12 12:32 pm

    The Motley Fool

    Read more
  • Value Investors Question SpaceX's Record IPO: 'It's The Future That Kills You'

    06/12 10:57 am

    Benzinga

    Read more
  • Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.

    06/11 02:02 pm

    The Motley Fool

    Read more
  • Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

    06/11 01:18 pm

    Investing.com

    Read more
  • Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

    06/10 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study

    06/08 02:06 pm

    Benzinga

    Read more
  • 3 Dividend Stocks to Buy Hand Over Fist in June

    06/07 01:30 am

    The Motley Fool

    Read more
  • Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.

    06/06 01:32 pm

    The Motley Fool

    Read more
  • Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems

    06/06 12:15 pm

    The Motley Fool

    Read more
  • Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

    06/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?

    06/04 02:30 am

    The Motley Fool

    Read more
  • Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

    06/03 04:00 am

    GlobeNewswire Inc.

    Read more
  • Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

    06/01 11:15 pm

    The Motley Fool

    Read more
  • AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

    06/01 02:19 pm

    The Motley Fool

    Read more
  • CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking

    06/01 12:30 pm

    The Motley Fool

    Read more
  • Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants

    05/28 02:00 pm

    GlobeNewswire Inc.

    Read more
  • This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe?

    05/25 05:15 pm

    The Motley Fool

    Read more
  • Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035

    05/25 05:31 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.

    05/25 05:05 am

    The Motley Fool

    Read more
  • Is Relay Therapeutics a Buy After Promising Trial Results?

    05/22 05:30 pm

    The Motley Fool

    Read more
  • The Most Important Healthcare Stock You're Not Watching

    05/22 05:15 pm

    The Motley Fool

    Read more
  • The Most Undervalued Healthcare Stock in the S&P 500 Right Now

    05/21 07:05 am

    The Motley Fool

    Read more
  • ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight

    05/20 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer Expands Pneumococcal Vaccine Push With New Programs

    05/20 09:14 am

    Benzinga

    Read more
  • Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

    05/19 01:00 pm

    GlobeNewswire Inc.

    Read more

🎁

Take 50% OFF With Code: